Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market.
PRRS, also known as Porcine Reproductive and Respiratory Syndrome, is a viral disease that occurs worldwide in all age groups. PRRD has two symptoms: reproductive failure or failure in breeding animals, and respiratory disease in pigs of any age.
Rising awareness about PRRS is driving the growth of the market. Another opportunity for the market includes increasing animal care spending and R&D activities in the veterinary biologics segment. Vaccinated pigs are expected to significantly reduce the frequency of wild-type virus transmission, helping to prevent dangerous diseases. Additionally, rising government investment is also expected to boost global demand for veterinary autologous vaccines during the forecast period. However, R&D costs may hinder the growth of the market.
Key Features:
The report on PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. It may include historical data, market segmentation by Type (e.g., CH-1R Strain, PC Strain), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine industry. This include advancements in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine technology, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine new entrants, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine new investment, and other innovations that are shaping the future of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market.
Market Segmentation:
PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market?
What factors are driving PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market opportunities vary by end market size?
How does PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market.
PRRS, also known as Porcine Reproductive and Respiratory Syndrome, is a viral disease that occurs worldwide in all age groups. PRRD has two symptoms: reproductive failure or failure in breeding animals, and respiratory disease in pigs of any age.
Rising awareness about PRRS is driving the growth of the market. Another opportunity for the market includes increasing animal care spending and R&D activities in the veterinary biologics segment. Vaccinated pigs are expected to significantly reduce the frequency of wild-type virus transmission, helping to prevent dangerous diseases. Additionally, rising government investment is also expected to boost global demand for veterinary autologous vaccines during the forecast period. However, R&D costs may hinder the growth of the market.
Key Features:
The report on PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. It may include historical data, market segmentation by Type (e.g., CH-1R Strain, PC Strain), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine industry. This include advancements in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine technology, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine new entrants, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine new investment, and other innovations that are shaping the future of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market.
Market Segmentation:
PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- CH-1R Strain
- PC Strain
- Others
- Gilts
- Sows
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- HIPRA
- Sinopharm Animal Health Co., Ltd
- Ceva Santй Animale
- CAVAC
- Bioveta
- Jinyu Bio-Technology
- Zoetis
- Boehringer Ingelheim
- Harbin Pharmaceutical Group
What is the 10-year outlook for the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market?
What factors are driving PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market opportunities vary by end market size?
How does PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country/Region, 2019, 2023 & 2030
2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type
2.2.1 CH-1R Strain
2.2.2 PC Strain
2.2.3 Others
2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
2.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Type (2019-2024)
2.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application
2.4.1 Gilts
2.4.2 Sows
2.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
2.5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Application (2019-2024)
3 GLOBAL PIG PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY COMPANY
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Breakdown Data by Company
3.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Company (2019-2024)
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (2019-2024)
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Company
3.4 Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Location Distribution
3.4.2 Players PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PIG PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY GEOGRAPHIC REGION
4.1 World Historic PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
4.4 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
4.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
4.6 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
5 AMERICAS
5.1 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
5.1.1 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024)
5.1.2 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024)
5.2 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
5.3 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region
6.1.1 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2019-2024)
6.1.2 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2019-2024)
6.2 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
6.3 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
7.1.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024)
7.1.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024)
7.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
7.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
8.1.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
8.3 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
10.3 Manufacturing Process Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
10.4 Industry Chain Structure of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
11.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customer
12 WORLD FORECAST REVIEW FOR PIG PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY GEOGRAPHIC REGION
12.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Region
12.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecast by Region (2025-2030)
12.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecast by Type
12.7 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 HIPRA
13.2.1 HIPRA Company Information
13.2.2 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 HIPRA Main Business Overview
13.2.5 HIPRA Latest Developments
13.3 Sinopharm Animal Health Co., Ltd
13.3.1 Sinopharm Animal Health Co., Ltd Company Information
13.3.2 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sinopharm Animal Health Co., Ltd Main Business Overview
13.3.5 Sinopharm Animal Health Co., Ltd Latest Developments
13.4 Ceva Santй Animale
13.4.1 Ceva Santй Animale Company Information
13.4.2 Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.4.3 Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ceva Santй Animale Main Business Overview
13.4.5 Ceva Santй Animale Latest Developments
13.5 CAVAC
13.5.1 CAVAC Company Information
13.5.2 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CAVAC Main Business Overview
13.5.5 CAVAC Latest Developments
13.6 Bioveta
13.6.1 Bioveta Company Information
13.6.2 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bioveta Main Business Overview
13.6.5 Bioveta Latest Developments
13.7 Jinyu Bio-Technology
13.7.1 Jinyu Bio-Technology Company Information
13.7.2 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.7.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Jinyu Bio-Technology Main Business Overview
13.7.5 Jinyu Bio-Technology Latest Developments
13.8 Zoetis
13.8.1 Zoetis Company Information
13.8.2 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zoetis Main Business Overview
13.8.5 Zoetis Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Harbin Pharmaceutical Group
13.10.1 Harbin Pharmaceutical Group Company Information
13.10.2 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Harbin Pharmaceutical Group Main Business Overview
13.10.5 Harbin Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country/Region, 2019, 2023 & 2030
2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type
2.2.1 CH-1R Strain
2.2.2 PC Strain
2.2.3 Others
2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
2.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Type (2019-2024)
2.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application
2.4.1 Gilts
2.4.2 Sows
2.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
2.5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Application (2019-2024)
3 GLOBAL PIG PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY COMPANY
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Breakdown Data by Company
3.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Company (2019-2024)
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (2019-2024)
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Company
3.4 Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Location Distribution
3.4.2 Players PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PIG PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY GEOGRAPHIC REGION
4.1 World Historic PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
4.4 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
4.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
4.6 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth
5 AMERICAS
5.1 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
5.1.1 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024)
5.1.2 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024)
5.2 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
5.3 Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region
6.1.1 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2019-2024)
6.1.2 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2019-2024)
6.2 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
6.3 APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
7.1.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024)
7.1.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024)
7.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
7.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Country
8.1.1 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
8.3 Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
10.3 Manufacturing Process Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
10.4 Industry Chain Structure of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
11.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customer
12 WORLD FORECAST REVIEW FOR PIG PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VACCINE BY GEOGRAPHIC REGION
12.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Region
12.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecast by Region (2025-2030)
12.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecast by Type
12.7 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 HIPRA
13.2.1 HIPRA Company Information
13.2.2 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 HIPRA Main Business Overview
13.2.5 HIPRA Latest Developments
13.3 Sinopharm Animal Health Co., Ltd
13.3.1 Sinopharm Animal Health Co., Ltd Company Information
13.3.2 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sinopharm Animal Health Co., Ltd Main Business Overview
13.3.5 Sinopharm Animal Health Co., Ltd Latest Developments
13.4 Ceva Santй Animale
13.4.1 Ceva Santй Animale Company Information
13.4.2 Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.4.3 Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Ceva Santй Animale Main Business Overview
13.4.5 Ceva Santй Animale Latest Developments
13.5 CAVAC
13.5.1 CAVAC Company Information
13.5.2 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CAVAC Main Business Overview
13.5.5 CAVAC Latest Developments
13.6 Bioveta
13.6.1 Bioveta Company Information
13.6.2 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bioveta Main Business Overview
13.6.5 Bioveta Latest Developments
13.7 Jinyu Bio-Technology
13.7.1 Jinyu Bio-Technology Company Information
13.7.2 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.7.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Jinyu Bio-Technology Main Business Overview
13.7.5 Jinyu Bio-Technology Latest Developments
13.8 Zoetis
13.8.1 Zoetis Company Information
13.8.2 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zoetis Main Business Overview
13.8.5 Zoetis Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Harbin Pharmaceutical Group
13.10.1 Harbin Pharmaceutical Group Company Information
13.10.2 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
13.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Harbin Pharmaceutical Group Main Business Overview
13.10.5 Harbin Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CH-1R Strain
Table 4. Major Players of PC Strain
Table 5. Major Players of Others
Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2019-2024)
Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Company (2019-2024) & (K Units)
Table 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Producing Area Distribution and Sales Area
Table 22. Players PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
Table 23. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024) & (K Units)
Table 35. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 39. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 40. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 45. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 46. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 51. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Table 59. Key Market Challenges & Risks of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Table 60. Key Industry Trends of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Table 61. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List
Table 64. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customer List
Table 65. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Merck Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 81. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. HIPRA Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 86. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. HIPRA Main Business
Table 88. HIPRA Latest Developments
Table 89. Sinopharm Animal Health Co., Ltd Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 91. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Sinopharm Animal Health Co., Ltd Main Business
Table 93. Sinopharm Animal Health Co., Ltd Latest Developments
Table 94. Ceva Santй Animale Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 96. Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Ceva Santй Animale Main Business
Table 98. Ceva Santй Animale Latest Developments
Table 99. CAVAC Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 101. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. CAVAC Main Business
Table 103. CAVAC Latest Developments
Table 104. Bioveta Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 106. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Bioveta Main Business
Table 108. Bioveta Latest Developments
Table 109. Jinyu Bio-Technology Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 111. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Jinyu Bio-Technology Main Business
Table 113. Jinyu Bio-Technology Latest Developments
Table 114. Zoetis Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 116. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Zoetis Main Business
Table 118. Zoetis Latest Developments
Table 119. Boehringer Ingelheim Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 121. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Boehringer Ingelheim Main Business
Table 123. Boehringer Ingelheim Latest Developments
Table 124. Harbin Pharmaceutical Group Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 126. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Harbin Pharmaceutical Group Main Business
Table 128. Harbin Pharmaceutical Group Latest Developments
Table 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CH-1R Strain
Table 4. Major Players of PC Strain
Table 5. Major Players of Others
Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Table 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2019-2024) & ($ million)
Table 9. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2019-2024)
Table 10. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Table 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2019-2024)
Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2019-2024)
Table 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Company (2019-2024) & (K Units)
Table 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Company (2019-2024)
Table 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company (2019-2024)
Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Producing Area Distribution and Sales Area
Table 22. Players PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Products Offered
Table 23. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Geographic Region (2019-2024)
Table 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country/Region (2019-2024)
Table 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024) & (K Units)
Table 35. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2019-2024)
Table 36. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2019-2024)
Table 38. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 39. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 40. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2019-2024) & (K Units)
Table 41. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2019-2024)
Table 42. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2019-2024)
Table 44. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 45. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 46. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2019-2024)
Table 48. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2019-2024)
Table 50. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 51. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Table 59. Key Market Challenges & Risks of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Table 60. Key Industry Trends of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Table 61. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List
Table 64. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customer List
Table 65. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Merck Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 81. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. HIPRA Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 86. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. HIPRA Main Business
Table 88. HIPRA Latest Developments
Table 89. Sinopharm Animal Health Co., Ltd Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 91. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Sinopharm Animal Health Co., Ltd Main Business
Table 93. Sinopharm Animal Health Co., Ltd Latest Developments
Table 94. Ceva Santй Animale Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 96. Ceva Santй Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Ceva Santй Animale Main Business
Table 98. Ceva Santй Animale Latest Developments
Table 99. CAVAC Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 101. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. CAVAC Main Business
Table 103. CAVAC Latest Developments
Table 104. Bioveta Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 106. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Bioveta Main Business
Table 108. Bioveta Latest Developments
Table 109. Jinyu Bio-Technology Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 111. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Jinyu Bio-Technology Main Business
Table 113. Jinyu Bio-Technology Latest Developments
Table 114. Zoetis Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 116. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Zoetis Main Business
Table 118. Zoetis Latest Developments
Table 119. Boehringer Ingelheim Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 121. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Boehringer Ingelheim Main Business
Table 123. Boehringer Ingelheim Latest Developments
Table 124. Harbin Pharmaceutical Group Basic Information, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolios and Specifications
Table 126. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Harbin Pharmaceutical Group Main Business
Table 128. Harbin Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 2. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CH-1R Strain
Figure 10. Product Picture of PC Strain
Figure 11. Product Picture of Others
Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type in 2023
Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumed in Gilts
Figure 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Gilts (2019-2024) & (K Units)
Figure 16. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumed in Sows
Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Sows (2019-2024) & (K Units)
Figure 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2023)
Figure 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application in 2023
Figure 20. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market by Company in 2023 (K Units)
Figure 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Company in 2023
Figure 22. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company in 2023
Figure 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Geographic Region in 2023
Figure 26. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 27. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 28. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 29. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 31. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country in 2023
Figure 35. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country in 2023
Figure 36. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 37. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 38. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region in 2023
Figure 43. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Regions in 2023
Figure 44. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 45. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 46. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country in 2023
Figure 54. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country in 2023
Figure 55. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 56. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 57. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country in 2023
Figure 63. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in 2023
Figure 72. Manufacturing Process Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 73. Industry Chain Structure of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 74. Channels of Distribution
Figure 75. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 2. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CH-1R Strain
Figure 10. Product Picture of PC Strain
Figure 11. Product Picture of Others
Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type in 2023
Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2019-2024)
Figure 14. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumed in Gilts
Figure 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Gilts (2019-2024) & (K Units)
Figure 16. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Consumed in Sows
Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market: Sows (2019-2024) & (K Units)
Figure 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2023)
Figure 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application in 2023
Figure 20. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market by Company in 2023 (K Units)
Figure 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Company in 2023
Figure 22. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company in 2023
Figure 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Geographic Region in 2023
Figure 26. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 27. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 28. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 29. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 30. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 31. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2019-2024 ($ Millions)
Figure 34. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country in 2023
Figure 35. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country in 2023
Figure 36. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 37. Americas PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 38. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region in 2023
Figure 43. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Regions in 2023
Figure 44. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 45. APAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 46. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country in 2023
Figure 54. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country in 2023
Figure 55. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 56. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 57. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country in 2023
Figure 63. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2019-2024)
Figure 66. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in 2023
Figure 72. Manufacturing Process Analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 73. Industry Chain Structure of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 74. Channels of Distribution
Figure 75. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Forecast by Region (2025-2030)
Figure 76. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share Forecast by Application (2025-2030)
